Merit Medical Q1 2019 Earnings Report
Growth Drivers
Growth Platforms
Multiple Growth Drivers
Revenue Growth Drivers
Non-GAAP EPS Growth Drivers
Organic Market
Growth
Product line
extensions and
innovations
Deleveraging
Opportunistic
M&A
Improving Organic
Gross Margin
Increasing
Operating Margin
New Product
International
Expansion
Introductions
Driven by our long
history of R&D (e.g.
Corvocet)
Several recent
product launches
Pipeline of new
products
Continued emphasis
on global expansion
Selectively choosing
to increase number of
direct markets
1111
✓ Opportunistic
acquisitions (e.g. BD,
Cianna)
Distribution deals
(e.g. SwiftNINJA,
Bluegrass Vascular,
NinePoint)
Launch of new
products driving a
shift in product mix
and improved organic
gross margins
Moving selected
manufacturing to
lower cost regions
✓ Streamlining
operations
✓ Synergies from
recent acquisitions
✓ Focus on utilizing a
portion of excess FCF
for debt repayment
to help drive EPS
growth
MA MERITMEDICA
6View entire presentation